Elmwood Wealth Management’s Gilead Sciences GILD Stock Holding History

Elmwood Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-539	Closed	-$39K	–	185
2021 Q4	$39K	Buy	+539	New	+$37.1K	0.02%	199
2021 Q2	$37K	Hold	539	–	–	0.02%	186
2021 Q1	$35K	Buy	+539	New	+$34.8K	0.02%	180
2020 Q3	$3K	Hold	39	–	–	﹤0.01%	226
2020 Q2	$3K	Buy	39 +27	+225%	+$2.07K	﹤0.01%	226
2020 Q1	$905	Buy	+12	New	+$829	﹤0.01%	280
2018 Q4	–	Sell	-12	Closed	-$927	–	295
2018 Q3	$927	Hold	12	–	–	﹤0.01%	273
2018 Q2	$850	Hold	12	–	–	﹤0.01%	275
2018 Q1	$905	Buy	+12	New	+$954	﹤0.01%	280

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Elmwood Wealth Management's GILD Position: Q1 2022 in Review

Elmwood Wealth Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 539 shares — an estimated $39K sold.

Elmwood Wealth Management first reported a position in GILD in Q1 2018 and held it in 9 quarters. The position peaked at $39K in Q4 2021. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Elmwood Wealth Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Elmwood Wealth Management sold 539 Gilead Sciences shares in Q1 2022, an estimated $39K.
Elmwood Wealth Management first reported a position in Gilead Sciences in Q1 2018 and held it in 9 quarters.
Elmwood Wealth Management's Gilead Sciences position peaked at $39K in Q4 2021.
1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Elmwood Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.